TFAP2B and lung carcinoma: In Fig. 7C, co-expression pattern of AP2α, AP2β and USP22 was shown in 4 representative tissues, demonstrating that a positive of either AP2α or AP2β IHC staining was frequently associated with a higher level of USP22 expression in lung cancer tissues.